Glucose Intolerance after a Recent History of Gestational Diabetes

Table 5

Comparison of the beta-cell function and the insulin sensitivity between women with an impaired fasting glucose (IFG) and women with an impaired glucose tolerance (IGT) postpartum.

	IFG; (21.2%)	IGT; (66.7%)	value	Adjusted value
pISSI-2 mean	1.3 ± 0.6	1.5 ± 0.4	0.211	0.927
pMatsuda (median)	2.2 (1.2–3.0)	3.0 (1.9–3.7)	0.132	0.695
p1/HOMA-IR; (median)	0.013 (0.010–0.018)	0.022 (0.013–0.034)	0.070	0.813
dISSI-2 (median)	1.4 (1.2–2.2)	1.7 (1.4–1.9)	0.221	0.629
dInsulinogenic index/HOMA-IR; (median)	0.005 (0.002–0.009)	0.010 (0.007–0.015)	0.003	0.087
dMatsuda (median)	3.2 (1.6–3.8)	4.8 (3.1–7.7)	0.004	0.075
d1/HOMA-IR (median)	0.020 (0.015–0.022)	0.038 (0.021–0.062)	<0.0001	0.016

pISSI-2: insulin secretion sensitivity index during pregnancy; pMatsuda: insulin sensitivity index of Matsuda during pregnancy; p1/HOMA-IR: the reciprocal of the homeostasis model assessment of insulin resistance during pregnancy; dISSI-2: insulin secretion sensitivity index postpartum; dMatsuda: insulin sensitivity index of Matsuda postpartum; dInsulinogenic index/HOMA-IR is a measure for beta-cell function postpartum; d1/HOMA-IR: the reciprocal of the homeostasis model assessment of insulin resistance postpartum; the values for the measurements during pregnancy and postpartum are adjusted for BMI.